Our research on the efficacy of EJW in treating AD by regulating cholesterol metabolism involved analyzing mRNA expression in the AGEs/RAGE/NF-κB pathway, informed by network pharmacology results. The gene discussed is NFKB1; the disease is Alzheimer disease.